557.1500 -8.25 (-1.46%)
NSE Jan 14, 2026 15:31 PM
Volume: 24,058
 

557.15
-1.46%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd.'s price crossed below 50Day SMA today
More from Solara Active Pharma Sciences Ltd.
Recommended